Page last updated: 2024-08-18

pyrroles and lysophosphatidylcholines

pyrroles has been researched along with lysophosphatidylcholines in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (66.67)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Choy, PC; Dembinski, T; Hatch, G; Kroeger, EA; McMaster, J; Mymin, D; Zhu, Q	1
Ameliushkina, VA; Kaminnyĭ, AI; Korotaeva, AA; Kucharchuk, VV; Naumov, VG; Pirkova, AA; Prokazova, NV; Samoĭlova, EV; Titov, VN	1
Liu, M; Martel-Pelletier, J; Pelletier, JP; Rahman, P; Randell, EW; Zhai, G	1

Trials

2 trial(s) available for pyrroles and lysophosphatidylcholines

Article	Year
[Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease]. Kardiologiia, 2007, Volume: 47, Issue:4 Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Group II Phospholipases A2; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lecithins; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Treatment Outcome; Triglycerides	2007
Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients. Arthritis research & therapy, 2019, 11-06, Volume: 21, Issue:1 Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase Inhibitors; Female; Humans; Lysophosphatidylcholines; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Phosphatidylcholines; Pyrroles; Treatment Outcome	2019

Article

Year

[Effect of atorvastatin therapy on the level of secretory phospholipase A2 group IIA and on the modification of low density lipoproteins in patients with ischemic heart disease].

Kardiologiia, 2007, Volume: 47, Issue:4

Topics: Aged; Anticholesteremic Agents; Atorvastatin; Cholesterol; Group II Phospholipases A2; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lecithins; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; Myocardial Ischemia; Pyrroles; Treatment Outcome; Triglycerides

2007

Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patients.

Arthritis research & therapy, 2019, 11-06, Volume: 21, Issue:1

Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; Cyclooxygenase Inhibitors; Female; Humans; Lysophosphatidylcholines; Male; Middle Aged; Naproxen; Osteoarthritis, Knee; Phosphatidylcholines; Pyrroles; Treatment Outcome

2019

Other Studies

1 other study(ies) available for pyrroles and lysophosphatidylcholines

Article	Year
Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients. Molecular and cellular biochemistry, 2000, Volume: 207, Issue:1-2 Topics: Adult; Anticholesteremic Agents; Atorvastatin; Combined Modality Therapy; Diet Therapy; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Oxidation-Reduction; Phospholipids; Pyrroles	2000

Article

Year

Effects of atorvastatin treatment on the oxidatively modified low density lipoprotein in hyperlipidemic patients.

Molecular and cellular biochemistry, 2000, Volume: 207, Issue:1-2

Topics: Adult; Anticholesteremic Agents; Atorvastatin; Combined Modality Therapy; Diet Therapy; Endothelium, Vascular; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Lysophosphatidylcholines; Muscle, Smooth, Vascular; Oxidation-Reduction; Phospholipids; Pyrroles

2000